Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) is the 1st best-performing stock year-to-date in this segment of the market. It has risen 220.83% since the beginning of this year. Its price percentage change was 450.00% for the last 52 weeks. Pharmasset, Inc. (NASDAQ:VRUS) is the 2nd best-performing stock year-to-date in this segment of the market. It has risen 158.82% since the beginning of this year. Its price percentage change was 335.29% for the last 52 weeks. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is the 3rd best-performing stock year-to-date in this segment of the market. It has risen 126.27% since the beginning of this year. Its price percentage change was 319.64% for the last 52 weeks.Nature's Sunshine Prod. (NASDAQ:NATR) is the 4th best-performing stock year-to-date in this segment of the market. It has risen 117.15% since the beginning of this year. Its price percentage change was 124.14% for the last 52 weeks. Vical Incorporated (NASDAQ:VICL) is the 5th best-performing stock year-to-date in this segment of the market. It has risen 103.47% since the beginning of this year. Its price percentage change was 31.31% for the last 52 weeks.Heska Corporation (NASDAQ:HSKAD) is the 6th best-performing stock year-to-date in this segment of the market. It has risen 91.43% since the beginning of this year. Its price percentage change was 43.86% for the last 52 weeks.Insmed Incorporated (NASDAQ:INSMD) is the 7th best-performing stock year-to-date in this segment of the market. It has risen 91.34% since the beginning of this year. Its price percentage change was 82.52% for the last 52 weeks.Valeant Pharmaceuticals Int (USA) (NYSE:VRX) is the 8th best-performing stock year-to-date in this segment of the market. It has risen 84.91% since the beginning of this year. Its price percentage change was 182.76% for the last 52 weeks. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) is the 9th best-performing stock year-to-date in this segment of the market. It has risen 83.84% since the beginning of this year. Its price percentage change was 83.84% for the last 52 weeks. Amarin Corporation plc (ADR) (NASDAQ:AMRN) is the 10th best-performing stock year-to-date in this segment of the market. It has risen 80.22% since the beginning of this year. Its price percentage change was 528.94% for the last 52 weeks.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment